Skip to main content

SHISEIDO FUTURE LX UNIVERSAL DEFENSE S

NDC 58411-902 · SHISEIDO AMERICAS CORPORATION

Generic nameOctisalate, Octocrylene, and Zinc Oxide
Dosage formCREAM
RouteTOPICAL
Active ingredient(s)OCTISALATE, OCTOCRYLENE, ZINC OXIDE
Strength1.44; 1.44; 9.7 g/50mL; g/50mL; g/50mL
Marketing categoryOTC MONOGRAPH DRUG

Packages

58411-902-60 — 1 TUBE in 1 CARTON (58411-902-60) / 50 mL in 1 TUBE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

58411-854 — AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE, 58411-856 — AVOBENZONE, OCTINOXATE, and OCTOCRYLENE, 58411-857 — AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE, 58411-888 — AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE, 58411-889 — AVOBENZONE, OCTINOXATE, and OCTOCRYLENE, 58411-890 — AVOBENZONE, OCTINOXATE, and OCTOCRYLENE, 58411-891 — AVOBENZONE, HOMOSALATE, OCTISALATE, and OCTOCRYLENE, 58411-892 — ENSULIZOLE, OCTINOXATE, and ZINC OXIDE, 58411-893 — Avobenzone, Homosalate, Octisalate, and Octocrylene, 58411-894 — Avobenzone, Octinoxate, and Octocrylene, 58411-903 — Titanium Dioxide and Zinc Oxide, 58411-905 — Avobenzone, Homosalate, Octisalate, Octocrylene, 58411-924 — Titanium Dioxide and Zinc Oxide, 58411-950 — Avobenzone, Homosalate, Octinoxate, Octocrylene, 58411-951 — Titanium Dioxide, Zinc Oxide, 58411-952 — Ensulizole, Homosalate, Octisalate, Zinc OXide, 58411-953 — Avobenzone, Octinoxate, Octocrylene, 58411-954 — Avobenzone, Homosalate, Octisalate, Octocrylene, 58411-955 — Avobenzone, Homosalate, Octisalate, Octocrylene, 58411-956 — Ensulizole, Octisalate, Octocrylene, Zinc Oxide, +7563 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels